Highlights:
- The Company closed the quarter with a cash position of $7.87 million.
- Manufacturing and distribution agreement with Knop Laboratories. The Company announced the execution of a strategic manufacturing and distribution agreement with Knop Laboratories. Knop Laboratories is a Chilean‐ based, independent pharmaceutical company with GMP manufacturing capability for Zelda’s cannabis medicines. Knop also operate a chain of pharmacies providing distribution capability once products are registered. (SA)
- The Company announced its clinical trial programme in Chile has expanded to include autism spectrum disorder (autism).
- The Company also reported that Zelda’s THC‐rich formulation had greater anti‐cancer effect than pure synthetic THC, across all cancer sub‐types including triple negative breast cancers.
Most we already knew, just need some confirmation on developments when each of these targets get hit. ZLD is one of the safer spec spaces currently imo. Some good pointers as we continue through the year, we are cashed up so continued trials should run without any worries about $.
DYOR. Best
- Forums
- ASX - By Stock
- ZLD
- Ann: June 2017 Quarterly Report
Ann: June 2017 Quarterly Report, page-3
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
81.5¢ |
Change
0.025(3.16%) |
Mkt cap ! $9.247M |
Open | High | Low | Value | Volume |
76.0¢ | 81.5¢ | 76.0¢ | $1.732K | 2.148K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 83.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 1021 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 0.830 |
1 | 530 | 0.760 |
2 | 1631 | 0.750 |
1 | 129 | 0.740 |
1 | 1327 | 0.710 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 1021 | 2 |
1.010 | 1000 | 1 |
1.020 | 5000 | 1 |
1.030 | 10000 | 1 |
1.050 | 6571 | 1 |
Last trade - 14.26pm 25/09/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online